About Kevin Hadi
Kevin Hadi is a Computational Biologist specializing in the application of AI to precision medicine, with numerous publications in top scientific journals and an h-index of 70.
Known information
Kevin Hadi is a Computational Biologist known for his expertise in applying artificial intelligence to precision medicine. He has made significant contributions to the field, with his research being published in prestigious journals such as the New England Journal of Medicine (NEJM), Nature Genetics, and Nature Medicine. Hadi’s work has earned him an impressive h-index of 70, reflecting his impactful and widely-cited research. He maintains professional profiles on LinkedIn, Google Scholar, and GitHub, where his work and contributions to the scientific community can be further explored.
About Isabl
Isabl, formerly known as Isabl Technologies, is a healthcare diagnostics company spun off from Memorial Sloan Kettering Cancer Center in 2020, headquartered in New York City. The company specializes in genomic diagnostics for cancer, offering comprehensive analysis tools and a remote-first work culture.